Recent Finacing
Recent Raise
Hepatera is a Skolkovo-based Russian biotech developing liver-disease therapeutics, co-developing Myrcludex B — an HBV/HDV entry inhibitor with MYR GmbH, completed Phase I and pursuing proof-of-concept trials.
Focus Areas
Recent Investors
Funding round
Investors